PRGO 8-K 2026-10-29

PERRIGO Co plc (PRGO) 8-K dated 2026-10-29 — accession 0001585364-26-000155.

PERRIGO Co plc (PRGO) is a drug manufacturers - specialty & generic company listed on US.

PERRIGO Co plc filed a 8-K on 2026-10-29. Accession 0001585364-26-000155.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PRGO revenue for 2025-12-31 was $4.25B. Net income was -$1.43B. Revenue was down 2.8% from 2024-12-31 to 2025-12-31. PRGO currently screens at market cap $1.48B.

Not investment advice. The PRGO SEC hub lists recent forms. The stock page is the research view.